The Medicare GLP-1 Discount Has One Big Catch: Some Sick Patients Don’t Qualify
The new Medicare GLP-1 Bridge program promises eligible beneficiaries access to popular weight loss drugs for as little as $50 a month. But for some, having the very medical conditions these drugs are approved to treat means they don't qualify for the discount.
The Medicare GLP-1 Bridge program offers $50 coverage for certain weight-loss medications, but it leaves out patients who use the drugs for FDA-approved conditions such as type 2 diabetes or sleep apnea. These patients must rely on their Medicare Part D plans, which may require expensive copays of $200–$600 per month. The program aims to help patients with a BMI of 35 or higher, or those with a BMI of 27 to 34 and specific health conditions, access GLP-1 medications.
However, the cost-sharing structure under Part D can make these drugs unaffordable for many beneficiaries, potentially leaving them worse off than before.
Written by urgent.news from Medical Xpress's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
